
EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection) - Global Forecast 2024-2030
Description
EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection) - Global Forecast 2024-2030
The EV-Based Liquid Biopsy Market size was estimated at USD 342.41 million in 2023 and expected to reach USD 414.56 million in 2024, at a CAGR 21.42% to reach USD 1,332.43 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the EV-Based Liquid Biopsy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the EV-Based Liquid Biopsy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the EV-Based Liquid Biopsy Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Techne Corporation, Biological Dynamics, ExosomeDx, Horiba Ltd., Lonza Group Ltd., Malvern Panalytical Ltd., Mercy BioAnalytics, Inc., Mursla Bio, Nanostics Inc., PerkinElmer, Inc., Qiagen N.V., and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the EV-Based Liquid Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Assay Kits
Instruments
Services
Application
Early Cancer Screening
Recurrence Monitoring
Therapy Selection
Treatment Monitoring
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the EV-Based Liquid Biopsy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the EV-Based Liquid Biopsy Market?
3. What are the technology trends and regulatory frameworks in the EV-Based Liquid Biopsy Market?
4. What is the market share of the leading vendors in the EV-Based Liquid Biopsy Market?
5. Which modes and strategic moves are suitable for entering the EV-Based Liquid Biopsy Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. EV-Based Liquid Biopsy Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of cancer cases among the population
- 5.1.1.2. Rising initiatives to promote healthcare awareness
- 5.1.1.3. Abundance and remarkable stability of exosomes compared to CfDNA or CTCs
- 5.1.2. Restraints
- 5.1.2.1. Issues associated with long duration and need for expensive equipment for EV-based liquid biopsy
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in EV-based liquid biopsy technologies
- 5.1.3.2. Growing popularity of precision medicine in oncology space
- 5.1.4. Challenges
- 5.1.4.1. Lack of standardized and clinically feasible EV purification & characterization protocols
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. EV-Based Liquid Biopsy Market, by Type
- 6.1. Introduction
- 6.2. Assay Kits
- 6.3. Instruments
- 6.4. Services
- 7. EV-Based Liquid Biopsy Market, by Application
- 7.1. Introduction
- 7.2. Early Cancer Screening
- 7.3. Recurrence Monitoring
- 7.4. Therapy Selection
- 7.5. Treatment Monitoring
- 8. Americas EV-Based Liquid Biopsy Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific EV-Based Liquid Biopsy Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa EV-Based Liquid Biopsy Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Abcam PLC
- 12.1.2. Bio-Techne Corporation
- 12.1.3. Biological Dynamics
- 12.1.4. ExosomeDx
- 12.1.5. Horiba Ltd.
- 12.1.6. Lonza Group Ltd.
- 12.1.7. Malvern Panalytical Ltd.
- 12.1.8. Mercy BioAnalytics, Inc.
- 12.1.9. Mursla Bio
- 12.1.10. Nanostics Inc.
- 12.1.11. PerkinElmer, Inc.
- 12.1.12. Qiagen N.V.
- 12.1.13. Thermo Fisher Scientific, Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
- FIGURE 2. EV-BASED LIQUID BIOPSY MARKET SIZE, 2023 VS 2030
- FIGURE 3. EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. EV-BASED LIQUID BIOPSY MARKET DYNAMICS
- FIGURE 7. EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.